Physician profile
Muhammad Raza
NPI 1629308150
$60,436.74
in general payments reported to CMS, 2019-2025
34 companies · $3,835 in 2025
The $3,835 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,917 · 2020: $3,649 · 2021: $12K · 2022: $23K · 2023: $4,097 · 2024: $5,741 · 2025: $3,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,091 · Travel and Lodging: $5,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,090.82 |
| Travel and Lodging | $5,581.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $34,027.72 | 2019-2023 | Xarelto |
| Janssen Scientific Affairs, LLC | $8,932.81 | 2019-2020 | |
| Edwards Lifesciences Corporation | $3,756.14 | 2020-2025 | Pascal, Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $2,932.91 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Medtronic, INC. | $2,381.89 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Ancora Heart, INC. | $2,346.80 | 2023-2025 | Accucinch |
| Boston Scientific Corporation | $1,608.40 | 2019-2025 | Avvigo Guidance System, Ingevity Mri, Eluvia |
| Abiomed | $604.23 | 2020-2024 | Impella |
| Medtronic Vascular, INC. | $587.02 | 2019-2020 | |
| Penumbra, INC. | $557.48 | 2024-2025 | Indigo System, Penumbra System |
| Biotronik INC. | $451.41 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Amgen INC. | $420.87 | 2019-2022 | |
| Pfizer INC. | $337.82 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $192.64 | 2023-2024 | Gore Cardioform Septal Occluder |
| Cardiac Dimensions, INC. | $147.19 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $138.71 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $117.23 | 2019-2023 | Brilinta |
| Chiesi USA, INC. | $115.90 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019-2025 | Lifevest |
| Philips North America LLC | $99.10 | 2025 | Igt Devices Undivided |
| Siemens Medical Solutions USA, INC. | $93.97 | 2024 | Magnetom Free.Max |
| Kestra Medical Technology Services, INC. | $76.80 | 2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $73.39 | 2019 | |
| Glaxosmithkline, LLC. | $61.75 | 2022-2024 | Zejula, Jemperli |
| Amarin Pharma, INC. | $61.29 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $47.50 | 2019 | |
| Angiodynamics, INC. | $35.35 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Teleflex LLC | $32.14 | 2024 | Manta |
| Endologix LLC | $21.89 | 2024 | Alto Abdominal Stent Graft System |
| Novartis Pharmaceuticals Corporation | $19.17 | 2020 | |
| Cardiva Medical, INC. | $17.33 | 2021 | |
| Terumo Medical Corporation | $14.88 | 2020 | |
| Biosense Webster, INC. | $13.95 | 2020 | |
| Acarix USA INC. | $11.06 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.